The Pancreatic Enzymes after Gastrectomy Trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501944-14-00

Acronym

PANEM

Enrollment

188

Registered

2023-04-24

Start date

2023-10-02

Completion date

Unknown

Last updated

2025-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients after gastrectomy (total and partial)

Brief summary

Disease specific quality of life (QOL) at 6 months according to the physical sub-score of the EORTC-QLQ-C30

Interventions

DRUGPlacebo to Test

DRUGNortase®

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Disease specific quality of life (QOL) at 6 months according to the physical sub-score of the EORTC-QLQ-C30	—

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026